Sunday, 14 April 2024

Business News

Island Pharma Reports Shift in Major Shareholder’s Stake – TipRanks Financial Blog

AC Immune opens new centers in Phase 1b/2 ACI-24 trial in AD and Down Syndrome

Island Pharmaceuticals Ltd (AU:ILA) has released an update.

Island Pharmaceuticals Ltd has announced a change in substantial holdings, where Albert Hansen’s voting power has decreased from 13.38% to 9.76% due to recent company activities, including the issuance of shares and participation in a rights issue. This shift follows corporate events such as shares issued as director fees and further investments by KESA Partners Inc.

For further insights into AU:ILA stock, check out TipRanks’ Stock Analysis page.

Click Here to Read the Full Original Article at TipRanks Financial Blog…